MedTrace Logo

Rectal Washout in Transanal Total Mesorectal Excision and Presence of Intraluminal Malignant Cells

NCT04730102 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 21

Last updated 2021-02-10

No results posted yet for this study

Summary

The study aims to assess the existence of intraluminal malignant cells and the appropriate fluid volume needed to perform rectal washout during transanal total mesorectal excision (taTME) for rectal cancer.

Conditions

Interventions

PROCEDURE

Rectal washout

Rectal washout is performed intraoperatively before transection and means irrigation of the rectum following the closure of the rectal lumen below the tumour with a purse string suture. Rectal washout is performed with a total of 500 ml sterile water. Fluid samples are collected after every 100 ml by instilling 50 ml of saline after each washout. A sixth sample is collected from the presacral cavity.

Sponsors & Collaborators

  • Skane University Hospital

    collaborator OTHER

  • Lund University

    collaborator OTHER

  • Slagelse Hospital

    lead OTHER

Principal Investigators

  • Pamela Buchwald · Skåne University Hospital, Malmö, Region Skåne, Sweden

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-13
Primary Completion
2021-02-09
Completion
2021-02-09

Countries

  • Denmark

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04730102 on ClinicalTrials.gov